Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials

BACKGROUND: Recent guidelines recommended a systolic blood pressure (SBP) target of < 130 mmHg for patients with or without diabetes but without providing a lower bound. Our study aimed to explore whether additional clinical benefits remain at achieved blood pressure (BP) levels below the recomme...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Chen, Kangyu, Shi, Guoshuai, Shi, Rui, Wu, Zhenqiang, Yuan, Xiaodan, Watson, Vicky, Jiang, Zhixin, Mai, Hui, Yang, Tian, Wang, Duolao, Chen, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208196/
https://www.ncbi.nlm.nih.gov/pubmed/35718771
http://dx.doi.org/10.1186/s12916-022-02407-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208196/
https://www.ncbi.nlm.nih.gov/pubmed/35718771
http://dx.doi.org/10.1186/s12916-022-02407-z

Ejemplares similares